Authors:
NISHIJIMA K
SHINKAWA T
YAMASHITA Y
SATO N
NISHIDA H
KATO K
ONUKI Y
MIZOTA M
OHTOMO K
MIYANO S
Citation: K. Nishijima et al., SYNTHESIS AND DIURETIC ACTIVITY OF 2,3-DIHYDRO-4(1H)-QUINOLINONE 4-OXIME-O-SULFONIC ACID-DERIVATIVES, European journal of medicinal chemistry, 33(4), 1998, pp. 267-277
Authors:
YAMADA H
UCHIGATA Y
KAWASAKI E
MATSUURA N
OTANI T
SATO A
MUTOH K
KASAHARA T
FUKUSHIMA N
KOIKE A
MIZOTA M
MIURA J
KUBO H
YAMAGUCHI A
NAGATAKI S
OMORI Y
IWAMOTO Y
Citation: H. Yamada et al., ONSET AGE-DEPENDENT VARIATIONS OF 3 ISLET-SPECIFIC AUTOANTIBODIES IN JAPANESE IDDM PATIENTS, Diabetes research and clinical practice, 39(3), 1998, pp. 211-217
Citation: M. Mizota et al., MOSSBAUER SPECTROSCOPIC STUDY ON IRON-CONTAINING BIOMINERALS IN THE LIMPET RADULA, Journal of the Physical Society of Japan, 67(2), 1998, pp. 679-681
Authors:
ISHIBASHI M
YAMASAKI F
NAKAKUKI M
SHINKAWA T
MIZOTA M
Citation: M. Ishibashi et al., CYTOPROTECTIVE EFFECT OF ULINASTATIN ON LLC-PK1 CELLS TREATED WITH ANTIMYCIN-A, GENTAMICIN, AND CISPLATIN, Nephron, 76(3), 1997, pp. 300-306
Authors:
MURAKAMI N
OHTA M
KATO K
NAKAYAMA K
MIZOTA M
MIWA I
OKUDA J
Citation: N. Murakami et al., EFFECTS OF 1-(3-BROMOBENZOFURAN-2-YLSULFONYL)HYDANTOIN ON HUMAN ALDOSE REDUCTASE EXAMINED BY A NEW APPLICATION OF HPLC SYSTEM FOR MEASURINGTISSUE POLYOL, Arzneimittel-Forschung, 47(11), 1997, pp. 1222-1225
Authors:
HASHIMOTO K
MURAKAMI N
OHTA M
KATO K
MIZOTA M
MIWA I
OKUDA J
Citation: K. Hashimoto et al., ACCELERATION OF GLYCOLYSIS IN ERYTHROCYTES BY THE ANTIDIABETIC AGENT M16209, Biological & pharmaceutical bulletin, 19(6), 1996, pp. 809-813
Authors:
SHIGEMORI M
KAWAKAMI K
KITAHARA T
IJICHI O
MIZOTA M
IKARIMOTO N
MIYATA K
Citation: M. Shigemori et al., HEPATOSPLENIC ABSCESS CAUSED BY CURVULARIA BOEDIJN IN A PATIENT WITH ACUTE MONOCYTIC LEUKEMIA, The Pediatric infectious disease journal, 15(12), 1996, pp. 1128-1129
Authors:
YAMASAKI F
SHINKAWA T
WATANABE M
MIZOTA M
Citation: F. Yamasaki et al., UPTAKE OF HUMAN URINARY TRYPSIN-INHIBITOR BY THE KIDNEY EPITHELIAL-CELL LINE, LLC-PK1, Pflugers Archiv, 433(1-2), 1996, pp. 9-15
Authors:
YAMASAKI F
ISHIBASHI M
NAKAKUKI M
WATANABE M
SHINKAWA T
MIZOTA M
Citation: F. Yamasaki et al., PROTECTIVE ACTION OF ULINASTATIN AGAINST CISPLATIN NEPHROTOXICITY IN MICE AND ITS EFFECT ON THE LYSOSOMAL FRAGILITY, Nephron, 74(1), 1996, pp. 158-167
Authors:
OHTA M
MURAKAMI N
KATO K
MIZOTA M
MIWA I
OKUDA J
YOSHIMASA Y
KUZUYA H
NAKAO K
IMURA H
Citation: M. Ohta et al., EFFECTS OF M16209, A NEW ANTIHYPERGLYCEMIC AGENT, ON INSULIN SENSITIVITY IN-VIVO - EUGLYCEMIC CLAMP STUDIES IN RATS, Metabolism, clinical and experimental, 45(9), 1996, pp. 1095-1100
Authors:
ABEI M
YANO T
KAWANO H
MIZUGUCHI K
MIZOTA M
SHODA J
MATSUZAKI Y
TANAKA N
OSUGA T
Citation: M. Abei et al., COMPARATIVE EFFECTS OF EICOSAPENTAENOIC ACID AND BEZAFIBRATE ON CHOLESTEROL GALLSTONE FORMATION IN HAMSTER, Gastroenterology, 110(4), 1996, pp. 1138-1138
Authors:
MURAKAMI N
OHTA M
HASHIMOTO K
KATO K
MIZOTA M
MIWA I
OKUDA J
INOUE G
KUZUYA H
NAKAO K
IMURA H
Citation: N. Murakami et al., AMELIORATION OF INSULIN-RESISTANCE IN GENETICALLY-OBESE RODENTS BY M16209, A NEW ANTIDIABETIC AGENT, European journal of pharmacology, 304(1-3), 1996, pp. 129-134
Authors:
UCHIGATA Y
MIZOTA M
YANAGISAWA K
NAKAGAWA Y
OTANI T
IKEGAMI H
YAMADA H
MIURA J
OGIHARA T
MATSUURA N
OMORI Y
Citation: Y. Uchigata et al., LARGE-SCALE STUDY OF AN A-TO-G TRANSITION AT POSITION-3243 OF THE MITOCHONDRIAL GENE AND IDDM IN JAPANESE PATIENTS, Diabetologia, 39(2), 1996, pp. 245-246
Authors:
NAKAKUKI M
YAMASAKI F
SHINKAWA T
KUDO M
WATANABE M
MIZOTA M
Citation: M. Nakakuki et al., PROTECTIVE EFFECT OF HUMAN ULINASTATIN AGAINST GENTAMICIN-INDUCED ACUTE-RENAL-FAILURE IN RATS, Canadian journal of physiology and pharmacology, 74(1), 1996, pp. 104-111
Authors:
IDA K
HASHIMOTO K
KAMIYA M
MUTO S
NAKAMURA Y
KATO K
MIZOTA M
Citation: K. Ida et al., STEREOSELECTIVE ACTION OF (R-ASTERISK,R-ASTERISK)-(+ 2-(3-CHLOROPHENYL)ETHYLAMINO]PROPYL]-PHENOXYACETIC ACID (BRL37344) ON BETA-ADRENOCEPTORS AND METABOLIC CHIRAL INVERSION/, Biochemical pharmacology, 52(10), 1996, pp. 1521-1527
Authors:
NAKAYAMA K
MURAKAMI N
OHTA M
KATO K
IDA K
MIZOTA M
MIWA I
OKUDA J
Citation: K. Nakayama et al., ANTIHYPERGLYCEMIC EFFECTS OF M16209, A NOVEL ALDOSE REDUCTASE INHIBITOR, IN NORMAL AND DIABETIC RATS, European journal of pharmacology, 276(1-2), 1995, pp. 77-83
Authors:
NAKAYAMA K
MURAKAMI N
OHTA M
KATO K
NOTSU T
MIZOTA M
MIWA I
OKUDA J
Citation: K. Nakayama et al., EFFECTS OF M16209 ON INSULIN-SECRETION IN ISOLATED, PERFUSED PANCREASES OF NORMAL AND DIABETIC RATS, European journal of pharmacology, 276(1-2), 1995, pp. 85-91
Authors:
SATO M
KATSUKI Y
FUKUHARA K
KAWANO H
MIZOTA M
HAMADA Y
KUNIHIRO Y
Citation: M. Sato et al., EFFECTS OF HIGHLY PURIFIED ETHYL ALL-CIS-5,8,11,14,17-ICOSAPENTAENOATE (EPA-E) ON RABBIT PLATELETS, Biological & pharmaceutical bulletin, 16(4), 1993, pp. 362-367
Authors:
SATO M
KATSUKI Y
KANEHIRO H
IIMURA M
AKADA Y
MIZOTA M
KUNIHIRO Y
Citation: M. Sato et al., EFFECTS OF ETHYL ALL-CIS-5,8,11,14,17-ICOSAPENTAENOATE ON THE PHYSICAL-PROPERTIES OF ARTERIAL-WALLS IN HIGH CHOLESTEROL DIET-FED RABBITS, Journal of cardiovascular pharmacology, 22(1), 1993, pp. 1-9
Authors:
SHINKAWA T
KATO Y
TSUCHIYA N
YAMASAKI F
UEMURA A
MIZOTA M
Citation: T. Shinkawa et al., BENEFICIAL EFFECT OF A NOVEL DIURETIC, M17055, ON BLOOD-PRESSURE AND CARDIOVASCULAR HYPERTROPHY IN SPONTANEOUSLY HYPERTENSIVE RATS, Japanese Journal of Pharmacology, 63(2), 1993, pp. 241-249
Authors:
MIZUGUCHI K
YANO T
ISHIBASHI M
MASADA A
MIZOTA M
SAITO Y
Citation: K. Mizuguchi et al., ETHYL ALL-CIS-5,8,11,14,17-ICOSAPENTAENOATE MODIFIES THE BIOCHEMICAL-PROPERTIES OF RAT VERY LOW-DENSITY-LIPOPROTEIN, European journal of pharmacology, 235(2-3), 1993, pp. 221-227